Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (430 views)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 3.527, 5-year impact factor: 2.675
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84885644488&partnerID=40&md5=9d91573034fa829438d5a964e3907c5d
Keywords: Differentiated Thyroid Cancer, Low-Risk Patients, Microcarcinoma, Radioiodine Therapy, Remnant Ablation, Iodine 131, Levothyroxine, Radioactive Iodine, Thyroglobulin, Thyroid Hormone, Thyrotropin, Adolescent, Adult, Aged, Article, Cancer Incidence, Cancer Risk, Clinical Feature, Computer Assisted Tomography, Controlled Study, Cytology, Echography, Female, Fine Needle Aspiration Biopsy, Human, Major Clinical Study, Overall Survival, Physical Examination, Priority Journal, Retrospective Study, Single Photon Emission Computer Tomography, Thyroid Carcinoma, Thyroid Microcarcinoma, Thyroidectomy, Tumor Ablation, Whole Body Scintiscanning, Iodine Radioisotopes, Lymph Node Excision, Middle Aged, Neoplasm, Residual, Retrospective Studies, Thyroid Neoplasms, Emission-Computed, Single-Photon, X-Ray Computed, Treatment Outcome, Tumor Burden, Whole Body Imaging, Carcinoma Diagnosis Pathology Radiotherapy Surgery , Iodine Radioisotopes Therapeutic Use , Thyroid Neoplasms Diagnosis Pathology Radiotherapy Surgery,
Affiliations:
*** IBB - CNR ***
Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Via P. Pio 1, 85028 Rionero in Vulture, Italy
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale Delle Ricerche (CNR), Naples, Italy
References:
Alevizaki, M., Papageorgiou, G., Rentziou, G., Saltiki, K., Marafelia, P., Loukari, E., Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: The majority are incidental (2009) Thyroid, 19, pp. 749-754. , 19534620 10.1089/thy.2008.042
Davies, L., Welch, H.G., Increasing incidence of thyroid cancer in the United States, 1973-2002 (2006) JAMA, 295, pp. 2164-2167. , 16684987 10.1001/jama.295.18.2164 1:CAS:528:DC%2BD28XksV2gtLg%3D
Dean, D.S., Hay, I.D., Prognostic indicators in differentiated thyroid carcinoma (2000) Cancer Control, 7, pp. 229-239. , 10832109 1:STN:280:DC%2BD3c3ptlGhtw%3D%3D
Schlumberger, M.J., Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status (1999) J. Endocrinol. Invest., 22, pp. 3-7. , 10726999 1:STN:280:DC%2BD3c7ovFGgsQ%3D%3D
Siironen, P., Louhimo, J., Nordling, S., Ristimaki, A., Maenpaa, H., Haapiainen, R., Prognostic factors in papillary thyroid cancer: An evaluation of 601 consecutive patients (2005) Tumour Biol., 26, pp. 57-64. , 15870511 10.1159/000085586
Haq, M., Harmer, C., Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome (2005) Clin. Endocrinol., 63, pp. 87-93. , 10.1111/j.1365-2265.2005.02304.x 1:STN:280:DC%2BD2MzhsFCiug%3D%3D
Hay, I.D., Thompson, G.B., Grant, C.S., Bergstralh, E.J., Dvorak, C.E., Gorman, C.A., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients (2002) World J. Surg., 26, pp. 879-885. , 12016468 10.1007/s00268-002-6612-1
Degroot, L.J., Kaplan, E.L., McCormick, M., Straus, F.H., Natural history, treatment, and course of papillary thyroid carcinoma (1990) J. Clin. Endocrinol. Metab., 71, pp. 414-424. , 2380337 10.1210/jcem-71-2-414 1:STN:280:DyaK3czjvVeisQ%3D%3D
Mazzaferri, E.L., Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma (1997) Thyroid, 7, pp. 265-271. , 9133698 10.1089/thy.1997.7.265 1:STN:280:DyaK2s3nvFWqsg%3D%3D
Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. 19860577 10.1089/thy.2009.0110
Jonklaas, J., Sarlis, N.J., Litofsky, D., Ain, K.B., Bigos, S.T., Brierley, J.D., Outcomes of patients with differentiated thyroid carcinoma following initial therapy (2006) Thyroid, 16, pp. 1229-1242. , 17199433 10.1089/thy.2006.16.1229
Pelizzo, M.R., Boschin, I.M., Toniato, A., Piotto, A., Bernante, P., Pagetta, C., Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients (2006) Eur. J. Surg. Oncol., 32, pp. 1144-1148. , 16872798 10.1016/j.ejso.2006.07.001 1:STN:280:DC%2BD28novVeruw%3D%3D
Ross, D.S., Litofsky, D., Ain, K.B., Bigos, T., Brierley, J.D., Cooper, D.S., Recurrence after treatment of micropapillary thyroid cancer (2009) Thyroid, 19, pp. 1043-1048. , 19772419 10.1089/thy.2008.0407
Samaan, N.A., Schultz, P.N., Hickey, R.C., Goepfert, H., Haynie, T.P., Johnston, D.A., The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients (1992) J. Clin. Endocrinol. Metab., 75, pp. 714-720. , 1517360 10.1210/jc.75.3.714 1:STN:280:DyaK38zovVenug%3D%3D
Mazzaferri, E.L., Jhiang, S.M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer (1994) Am. J. Med., 97, pp. 418-428. , 7977430 10.1016/0002-9343(94)90321-2 1:STN:280:DyaK2M%2FmvVSgtA%3D%3D
Mazzaferri, E.L., Kloos, R.T., Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer (2001) J. Clin. Endocrinol. Metab., 86, pp. 1447-1463. , 11297567 10.1210/jc.86.4.1447 1:CAS:528:DC%2BD3MXivVCltLw%3D
Sawka, A.M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H.C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89, pp. 3668-3676. , 15292285 10.1210/jc.2003-031167 1:CAS:528:DC%2BD2cXmslKmsbc%3D
Sugitani, I., Fujimoto, Y., Symptomatic versus asymptomatic papillary thyroid microcarcinoma: A retrospective analysis of surgical outcome and prognostic factors (1999) Endocr. J., 46, pp. 209-216. , 10426589 10.1507/endocrj.46.209 1:STN:280:DyaK1MzltlKlsw%3D%3D
Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J.W., Wiersinga, W., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium (2006) Eur. J. Endocrinol., 154, pp. 787-803. , European Thyroid Cancer Taskforce 16728537 10.1530/eje.1.02158 1:CAS:528:DC%2BD28XmsVKrurY%3D
McDougall, I.R., Hay, I.D., ATA Guidelines: Do patients with stage i thyroid cancer benefit from (131)I? (2007) Thyroid, 17, pp. 595-596. , 17614785 10.1089/thy.2007.0203
Machens, A., Hinze, R., Thomusch, O., Dralle, H., Pattern of nodal metastasis for primary and reoperative thyroid cancer (2002) World J. Surg., 26, pp. 22-28. , 11898029 10.1007/s00268-001-0176-3
Hay, I.D., Grant, C.S., Van Heerden, J.A., Goellner, J.R., Ebersold, J.R., Bergstralh, E.J., Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period (1992) Surgery, 112, pp. 1139-1146. , 1455316 1:STN:280:DyaK3s%2FovVWltQ%3D%3D
Bonnet, S., Hartl, D., Leboulleux, S., Baudin, E., Lumbroso, J.D., Al Ghuzlan, A., Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: Implications for radioiodine treatment (2009) J. Clin. Endocrinol. Metab., 94, pp. 1162-1167. , 19116234 10.1210/jc.2008-1931 1:CAS:528:DC%2BD1MXksFait7k%3D
Conzo, G., Pasquali, D., Bellastella, G., Esposito, K., Carella, C., De Bellis, A., Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases (2013) Endocrine, , (Epub ahead of print)
Kim, E.Y., Kim, W.G., Kim, W.B., Kim, T.Y., Ryu, J.S., Gong, G., Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation (2010) Clin. Endocrinol., 73, pp. 257-263
Wong, K.K., Zarzhevsky, N., Cahill, J.M., Frey, K.A., Avram, A.M., Hybrid SPECT/CT and PET-CT imaging of differentiated thyroid carcinoma (2009) Br. J. Radiol., 82, pp. 860-876. , 19433487 10.1259/bjr/25645894 1:STN:280:DC%2BD1MnislCntw%3D%3D
Mazzaferri, E.L., Managing small thyroid cancers (2006) JAMA, 295, pp. 2179-2182. , 16684990 10.1001/jama.295.18.2179 1:CAS:528:DC%2BD28XksV2gur8%3D
Lloyd, R., Delellis, R., Heitz, P., Eng, C., (2004) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Endocrine Organs, , IARC Press International Agency for Research on Cancer Lyon
Lang, B.H., Lo, C.Y., Chan, W.F., Lam, K.Y., Wan, K.Y., Prognostic factors in papillary and follicular thyroid carcinoma: Their implications for cancer staging (2007) Ann. Surg. Oncol., 14, pp. 730-738. , 17103065 10.1245/s10434-006-9207-5
Machens, A., Holzhausen, H.J., Dralle, H., The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma (2005) Cancer, 103, pp. 2269-2273. , 15856429 10.1002/cncr.21055
Pagano, L., Caputo, M., Samà, M.T., Garbaccio, V., Zavattaro, M., Mauri, M.G., Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): Data from the University Hospital "maggiore della Carità" in Novara (2012) Endocrine, 42, pp. 382-390. , 22315013 10.1007/s12020-012-9612-4 1:CAS:528:DC%2BC38XhvVGmtL8%3D
García-Pascual, L., Balsells, M., Fabbi, M., Pozo, C.D., Valverde, M.T., Casalots, J., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group (2011) Endocrine, 40, pp. 423-431. , 21541652 10.1007/s12020-011-9479-9
Wartofsky, L., Van Nostrand, D., Radioiodine treatment of well-differentiated thyroid cancer (2012) Endocrine, 42, pp. 506-513. , 22733393 10.1007/s12020-012-9729-5 1:CAS:528:DC%2BC38XptFagsLk%3D
Hay, I.D., Hutchinson, M.E., Gonzalez-Losada, T., McIver, B., Reinalda, M.E., Grant, C.S., Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period (2009) Surgery, 144, pp. 980-987. , 10.1016/j.surg.2008.08.035
Baudin, E., Travagli, J.P., Ropers, J., Mancusi, F., Bruno-Bossio, G., Caillou, B., Microcarcinoma of the thyroid gland: The Gustave-Roussy Institute experience (1998) Cancer, 83, pp. 553-559. , 9690549 10.1002/(SICI)1097-0142(19980801)83:3<553: AID-CNCR25>3.0.CO
2-U 1:STN:280:DyaK1czlt1ymuw%3D%3D
Katoh, R., Sasaki, J., Kurihara, H., Suzuki, K., Iida, Y., Kawaoi, A., Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients (1992) Cancer, 70, pp. 1585-1590. , 1516009 10.1002/1097-0142(19920915)70:6<1585: AID-CNCR2820700623>3. 0.CO
2-Z 1:STN:280:DyaK38zos1ChtQ%3D%3D
Dean, D. S., Hay, I. D., Prognostic indicators in differentiated thyroid carcinoma (2000) Cancer Control, 7, pp. 229-239. , 10832109 1: STN: 280: DC%2BD3c3ptlGhtw%3D%3D
Schlumberger, M. J., Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status (1999) J. Endocrinol. Invest., 22, pp. 3-7. , 10726999 1: STN: 280: DC%2BD3c7ovFGgsQ%3D%3D
Hay, I. D., Thompson, G. B., Grant, C. S., Bergstralh, E. J., Dvorak, C. E., Gorman, C. A., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients (2002) World J. Surg., 26, pp. 879-885. , 12016468 10. 1007/s00268-002-6612-1
Degroot, L. J., Kaplan, E. L., McCormick, M., Straus, F. H., Natural history, treatment, and course of papillary thyroid carcinoma (1990) J. Clin. Endocrinol. Metab., 71, pp. 414-424. , 2380337 10. 1210/jcem-71-2-414 1: STN: 280: DyaK3czjvVeisQ%3D%3D
Mazzaferri, E. L., Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma (1997) Thyroid, 7, pp. 265-271. , 9133698 10. 1089/thy. 1997. 7. 265 1: STN: 280: DyaK2s3nvFWqsg%3D%3D
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. 19860577 10. 1089/thy. 2009. 0110
Pelizzo, M. R., Boschin, I. M., Toniato, A., Piotto, A., Bernante, P., Pagetta, C., Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients (2006) Eur. J. Surg. Oncol., 32, pp. 1144-1148. , 16872798 10. 1016/j. ejso. 2006. 07. 001 1: STN: 280: DC%2BD28novVeruw%3D%3D
Ross, D. S., Litofsky, D., Ain, K. B., Bigos, T., Brierley, J. D., Cooper, D. S., Recurrence after treatment of micropapillary thyroid cancer (2009) Thyroid, 19, pp. 1043-1048. , 19772419 10. 1089/thy. 2008. 0407
Samaan, N. A., Schultz, P. N., Hickey, R. C., Goepfert, H., Haynie, T. P., Johnston, D. A., The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients (1992) J. Clin. Endocrinol. Metab., 75, pp. 714-720. , 1517360 10. 1210/jc. 75. 3. 714 1: STN: 280: DyaK38zovVenug%3D%3D
Sawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H. C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89, pp. 3668-3676. , 15292285 10. 1210/jc. 2003-031167 1: CAS: 528: DC%2BD2cXmslKmsbc%3D
McDougall, I. R., Hay, I. D., ATA Guidelines: Do patients with stage i thyroid cancer benefit from (131) I? (2007) Thyroid, 17, pp. 595-596. , 17614785 10. 1089/thy. 2007. 0203
Hay, I. D., Grant, C. S., Van Heerden, J. A., Goellner, J. R., Ebersold, J. R., Bergstralh, E. J., Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period (1992) Surgery, 112, pp. 1139-1146. , 1455316 1: STN: 280: DyaK3s%2FovVWltQ%3D%3D
Kim, E. Y., Kim, W. G., Kim, W. B., Kim, T. Y., Ryu, J. S., Gong, G., Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation (2010) Clin. Endocrinol., 73, pp. 257-263
Wong, K. K., Zarzhevsky, N., Cahill, J. M., Frey, K. A., Avram, A. M., Hybrid SPECT/CT and PET-CT imaging of differentiated thyroid carcinoma (2009) Br. J. Radiol., 82, pp. 860-876. , 19433487 10. 1259/bjr/25645894 1: STN: 280: DC%2BD1MnislCntw%3D%3D
Lang, B. H., Lo, C. Y., Chan, W. F., Lam, K. Y., Wan, K. Y., Prognostic factors in papillary and follicular thyroid carcinoma: Their implications for cancer staging (2007) Ann. Surg. Oncol., 14, pp. 730-738. , 17103065 10. 1245/s10434-006-9207-5
Garc a-Pascual, L., Balsells, M., Fabbi, M., Pozo, C. D., Valverde, M. T., Casalots, J., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group (2011) Endocrine, 40, pp. 423-431. , 21541652 10. 1007/s12020-011-9479-9
Hay, I. D., Hutchinson, M. E., Gonzalez-Losada, T., McIver, B., Reinalda, M. E., Grant, C. S., Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period (2009) Surgery, 144, pp. 980-987. , 10. 1016/j. surg. 2008. 08. 035
2-U 1: STN: 280: DyaK1czlt1ymuw%3D%3D
2-Z 1: STN: 280: DyaK38zos1ChtQ%3D%3D
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 3.527, 5-year impact factor: 2.675
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84885644488&partnerID=40&md5=9d91573034fa829438d5a964e3907c5d
Keywords: Differentiated Thyroid Cancer, Low-Risk Patients, Microcarcinoma, Radioiodine Therapy, Remnant Ablation, Iodine 131, Levothyroxine, Radioactive Iodine, Thyroglobulin, Thyroid Hormone, Thyrotropin, Adolescent, Adult, Aged, Article, Cancer Incidence, Cancer Risk, Clinical Feature, Computer Assisted Tomography, Controlled Study, Cytology, Echography, Female, Fine Needle Aspiration Biopsy, Human, Major Clinical Study, Overall Survival, Physical Examination, Priority Journal, Retrospective Study, Single Photon Emission Computer Tomography, Thyroid Carcinoma, Thyroid Microcarcinoma, Thyroidectomy, Tumor Ablation, Whole Body Scintiscanning, Iodine Radioisotopes, Lymph Node Excision, Middle Aged, Neoplasm, Residual, Retrospective Studies, Thyroid Neoplasms, Emission-Computed, Single-Photon, X-Ray Computed, Treatment Outcome, Tumor Burden, Whole Body Imaging, Carcinoma Diagnosis Pathology Radiotherapy Surgery , Iodine Radioisotopes Therapeutic Use , Thyroid Neoplasms Diagnosis Pathology Radiotherapy Surgery,
Affiliations:
*** IBB - CNR ***
Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Via P. Pio 1, 85028 Rionero in Vulture, Italy
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale Delle Ricerche (CNR), Naples, Italy
References:
Alevizaki, M., Papageorgiou, G., Rentziou, G., Saltiki, K., Marafelia, P., Loukari, E., Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: The majority are incidental (2009) Thyroid, 19, pp. 749-754. , 19534620 10.1089/thy.2008.042
Davies, L., Welch, H.G., Increasing incidence of thyroid cancer in the United States, 1973-2002 (2006) JAMA, 295, pp. 2164-2167. , 16684987 10.1001/jama.295.18.2164 1:CAS:528:DC%2BD28XksV2gtLg%3D
Dean, D.S., Hay, I.D., Prognostic indicators in differentiated thyroid carcinoma (2000) Cancer Control, 7, pp. 229-239. , 10832109 1:STN:280:DC%2BD3c3ptlGhtw%3D%3D
Schlumberger, M.J., Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status (1999) J. Endocrinol. Invest., 22, pp. 3-7. , 10726999 1:STN:280:DC%2BD3c7ovFGgsQ%3D%3D
Siironen, P., Louhimo, J., Nordling, S., Ristimaki, A., Maenpaa, H., Haapiainen, R., Prognostic factors in papillary thyroid cancer: An evaluation of 601 consecutive patients (2005) Tumour Biol., 26, pp. 57-64. , 15870511 10.1159/000085586
Haq, M., Harmer, C., Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome (2005) Clin. Endocrinol., 63, pp. 87-93. , 10.1111/j.1365-2265.2005.02304.x 1:STN:280:DC%2BD2MzhsFCiug%3D%3D
Hay, I.D., Thompson, G.B., Grant, C.S., Bergstralh, E.J., Dvorak, C.E., Gorman, C.A., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients (2002) World J. Surg., 26, pp. 879-885. , 12016468 10.1007/s00268-002-6612-1
Degroot, L.J., Kaplan, E.L., McCormick, M., Straus, F.H., Natural history, treatment, and course of papillary thyroid carcinoma (1990) J. Clin. Endocrinol. Metab., 71, pp. 414-424. , 2380337 10.1210/jcem-71-2-414 1:STN:280:DyaK3czjvVeisQ%3D%3D
Mazzaferri, E.L., Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma (1997) Thyroid, 7, pp. 265-271. , 9133698 10.1089/thy.1997.7.265 1:STN:280:DyaK2s3nvFWqsg%3D%3D
Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. 19860577 10.1089/thy.2009.0110
Jonklaas, J., Sarlis, N.J., Litofsky, D., Ain, K.B., Bigos, S.T., Brierley, J.D., Outcomes of patients with differentiated thyroid carcinoma following initial therapy (2006) Thyroid, 16, pp. 1229-1242. , 17199433 10.1089/thy.2006.16.1229
Pelizzo, M.R., Boschin, I.M., Toniato, A., Piotto, A., Bernante, P., Pagetta, C., Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients (2006) Eur. J. Surg. Oncol., 32, pp. 1144-1148. , 16872798 10.1016/j.ejso.2006.07.001 1:STN:280:DC%2BD28novVeruw%3D%3D
Ross, D.S., Litofsky, D., Ain, K.B., Bigos, T., Brierley, J.D., Cooper, D.S., Recurrence after treatment of micropapillary thyroid cancer (2009) Thyroid, 19, pp. 1043-1048. , 19772419 10.1089/thy.2008.0407
Samaan, N.A., Schultz, P.N., Hickey, R.C., Goepfert, H., Haynie, T.P., Johnston, D.A., The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients (1992) J. Clin. Endocrinol. Metab., 75, pp. 714-720. , 1517360 10.1210/jc.75.3.714 1:STN:280:DyaK38zovVenug%3D%3D
Mazzaferri, E.L., Jhiang, S.M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer (1994) Am. J. Med., 97, pp. 418-428. , 7977430 10.1016/0002-9343(94)90321-2 1:STN:280:DyaK2M%2FmvVSgtA%3D%3D
Mazzaferri, E.L., Kloos, R.T., Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer (2001) J. Clin. Endocrinol. Metab., 86, pp. 1447-1463. , 11297567 10.1210/jc.86.4.1447 1:CAS:528:DC%2BD3MXivVCltLw%3D
Sawka, A.M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H.C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89, pp. 3668-3676. , 15292285 10.1210/jc.2003-031167 1:CAS:528:DC%2BD2cXmslKmsbc%3D
Sugitani, I., Fujimoto, Y., Symptomatic versus asymptomatic papillary thyroid microcarcinoma: A retrospective analysis of surgical outcome and prognostic factors (1999) Endocr. J., 46, pp. 209-216. , 10426589 10.1507/endocrj.46.209 1:STN:280:DyaK1MzltlKlsw%3D%3D
Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J.W., Wiersinga, W., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium (2006) Eur. J. Endocrinol., 154, pp. 787-803. , European Thyroid Cancer Taskforce 16728537 10.1530/eje.1.02158 1:CAS:528:DC%2BD28XmsVKrurY%3D
McDougall, I.R., Hay, I.D., ATA Guidelines: Do patients with stage i thyroid cancer benefit from (131)I? (2007) Thyroid, 17, pp. 595-596. , 17614785 10.1089/thy.2007.0203
Machens, A., Hinze, R., Thomusch, O., Dralle, H., Pattern of nodal metastasis for primary and reoperative thyroid cancer (2002) World J. Surg., 26, pp. 22-28. , 11898029 10.1007/s00268-001-0176-3
Hay, I.D., Grant, C.S., Van Heerden, J.A., Goellner, J.R., Ebersold, J.R., Bergstralh, E.J., Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period (1992) Surgery, 112, pp. 1139-1146. , 1455316 1:STN:280:DyaK3s%2FovVWltQ%3D%3D
Bonnet, S., Hartl, D., Leboulleux, S., Baudin, E., Lumbroso, J.D., Al Ghuzlan, A., Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: Implications for radioiodine treatment (2009) J. Clin. Endocrinol. Metab., 94, pp. 1162-1167. , 19116234 10.1210/jc.2008-1931 1:CAS:528:DC%2BD1MXksFait7k%3D
Conzo, G., Pasquali, D., Bellastella, G., Esposito, K., Carella, C., De Bellis, A., Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases (2013) Endocrine, , (Epub ahead of print)
Kim, E.Y., Kim, W.G., Kim, W.B., Kim, T.Y., Ryu, J.S., Gong, G., Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation (2010) Clin. Endocrinol., 73, pp. 257-263
Wong, K.K., Zarzhevsky, N., Cahill, J.M., Frey, K.A., Avram, A.M., Hybrid SPECT/CT and PET-CT imaging of differentiated thyroid carcinoma (2009) Br. J. Radiol., 82, pp. 860-876. , 19433487 10.1259/bjr/25645894 1:STN:280:DC%2BD1MnislCntw%3D%3D
Mazzaferri, E.L., Managing small thyroid cancers (2006) JAMA, 295, pp. 2179-2182. , 16684990 10.1001/jama.295.18.2179 1:CAS:528:DC%2BD28XksV2gur8%3D
Lloyd, R., Delellis, R., Heitz, P., Eng, C., (2004) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Endocrine Organs, , IARC Press International Agency for Research on Cancer Lyon
Lang, B.H., Lo, C.Y., Chan, W.F., Lam, K.Y., Wan, K.Y., Prognostic factors in papillary and follicular thyroid carcinoma: Their implications for cancer staging (2007) Ann. Surg. Oncol., 14, pp. 730-738. , 17103065 10.1245/s10434-006-9207-5
Machens, A., Holzhausen, H.J., Dralle, H., The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma (2005) Cancer, 103, pp. 2269-2273. , 15856429 10.1002/cncr.21055
Pagano, L., Caputo, M., Samà, M.T., Garbaccio, V., Zavattaro, M., Mauri, M.G., Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): Data from the University Hospital "maggiore della Carità" in Novara (2012) Endocrine, 42, pp. 382-390. , 22315013 10.1007/s12020-012-9612-4 1:CAS:528:DC%2BC38XhvVGmtL8%3D
García-Pascual, L., Balsells, M., Fabbi, M., Pozo, C.D., Valverde, M.T., Casalots, J., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group (2011) Endocrine, 40, pp. 423-431. , 21541652 10.1007/s12020-011-9479-9
Wartofsky, L., Van Nostrand, D., Radioiodine treatment of well-differentiated thyroid cancer (2012) Endocrine, 42, pp. 506-513. , 22733393 10.1007/s12020-012-9729-5 1:CAS:528:DC%2BC38XptFagsLk%3D
Hay, I.D., Hutchinson, M.E., Gonzalez-Losada, T., McIver, B., Reinalda, M.E., Grant, C.S., Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period (2009) Surgery, 144, pp. 980-987. , 10.1016/j.surg.2008.08.035
Baudin, E., Travagli, J.P., Ropers, J., Mancusi, F., Bruno-Bossio, G., Caillou, B., Microcarcinoma of the thyroid gland: The Gustave-Roussy Institute experience (1998) Cancer, 83, pp. 553-559. , 9690549 10.1002/(SICI)1097-0142(19980801)83:3<553: AID-CNCR25>3.0.CO
2-U 1:STN:280:DyaK1czlt1ymuw%3D%3D
Katoh, R., Sasaki, J., Kurihara, H., Suzuki, K., Iida, Y., Kawaoi, A., Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients (1992) Cancer, 70, pp. 1585-1590. , 1516009 10.1002/1097-0142(19920915)70:6<1585: AID-CNCR2820700623>3. 0.CO
2-Z 1:STN:280:DyaK38zos1ChtQ%3D%3D
Dean, D. S., Hay, I. D., Prognostic indicators in differentiated thyroid carcinoma (2000) Cancer Control, 7, pp. 229-239. , 10832109 1: STN: 280: DC%2BD3c3ptlGhtw%3D%3D
Schlumberger, M. J., Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status (1999) J. Endocrinol. Invest., 22, pp. 3-7. , 10726999 1: STN: 280: DC%2BD3c7ovFGgsQ%3D%3D
Hay, I. D., Thompson, G. B., Grant, C. S., Bergstralh, E. J., Dvorak, C. E., Gorman, C. A., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients (2002) World J. Surg., 26, pp. 879-885. , 12016468 10. 1007/s00268-002-6612-1
Degroot, L. J., Kaplan, E. L., McCormick, M., Straus, F. H., Natural history, treatment, and course of papillary thyroid carcinoma (1990) J. Clin. Endocrinol. Metab., 71, pp. 414-424. , 2380337 10. 1210/jcem-71-2-414 1: STN: 280: DyaK3czjvVeisQ%3D%3D
Mazzaferri, E. L., Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma (1997) Thyroid, 7, pp. 265-271. , 9133698 10. 1089/thy. 1997. 7. 265 1: STN: 280: DyaK2s3nvFWqsg%3D%3D
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. 19860577 10. 1089/thy. 2009. 0110
Pelizzo, M. R., Boschin, I. M., Toniato, A., Piotto, A., Bernante, P., Pagetta, C., Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients (2006) Eur. J. Surg. Oncol., 32, pp. 1144-1148. , 16872798 10. 1016/j. ejso. 2006. 07. 001 1: STN: 280: DC%2BD28novVeruw%3D%3D
Ross, D. S., Litofsky, D., Ain, K. B., Bigos, T., Brierley, J. D., Cooper, D. S., Recurrence after treatment of micropapillary thyroid cancer (2009) Thyroid, 19, pp. 1043-1048. , 19772419 10. 1089/thy. 2008. 0407
Samaan, N. A., Schultz, P. N., Hickey, R. C., Goepfert, H., Haynie, T. P., Johnston, D. A., The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients (1992) J. Clin. Endocrinol. Metab., 75, pp. 714-720. , 1517360 10. 1210/jc. 75. 3. 714 1: STN: 280: DyaK38zovVenug%3D%3D
Sawka, A. M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H. C., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J. Clin. Endocrinol. Metab., 89, pp. 3668-3676. , 15292285 10. 1210/jc. 2003-031167 1: CAS: 528: DC%2BD2cXmslKmsbc%3D
McDougall, I. R., Hay, I. D., ATA Guidelines: Do patients with stage i thyroid cancer benefit from (131) I? (2007) Thyroid, 17, pp. 595-596. , 17614785 10. 1089/thy. 2007. 0203
Hay, I. D., Grant, C. S., Van Heerden, J. A., Goellner, J. R., Ebersold, J. R., Bergstralh, E. J., Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period (1992) Surgery, 112, pp. 1139-1146. , 1455316 1: STN: 280: DyaK3s%2FovVWltQ%3D%3D
Kim, E. Y., Kim, W. G., Kim, W. B., Kim, T. Y., Ryu, J. S., Gong, G., Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation (2010) Clin. Endocrinol., 73, pp. 257-263
Wong, K. K., Zarzhevsky, N., Cahill, J. M., Frey, K. A., Avram, A. M., Hybrid SPECT/CT and PET-CT imaging of differentiated thyroid carcinoma (2009) Br. J. Radiol., 82, pp. 860-876. , 19433487 10. 1259/bjr/25645894 1: STN: 280: DC%2BD1MnislCntw%3D%3D
Lang, B. H., Lo, C. Y., Chan, W. F., Lam, K. Y., Wan, K. Y., Prognostic factors in papillary and follicular thyroid carcinoma: Their implications for cancer staging (2007) Ann. Surg. Oncol., 14, pp. 730-738. , 17103065 10. 1245/s10434-006-9207-5
Garc a-Pascual, L., Balsells, M., Fabbi, M., Pozo, C. D., Valverde, M. T., Casalots, J., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery. Comparison with a control group (2011) Endocrine, 40, pp. 423-431. , 21541652 10. 1007/s12020-011-9479-9
Hay, I. D., Hutchinson, M. E., Gonzalez-Losada, T., McIver, B., Reinalda, M. E., Grant, C. S., Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period (2009) Surgery, 144, pp. 980-987. , 10. 1016/j. surg. 2008. 08. 035
2-U 1: STN: 280: DyaK1czlt1ymuw%3D%3D
2-Z 1: STN: 280: DyaK38zos1ChtQ%3D%3D
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer <1 cm, in the absence of other higher risk features. We retrospectively studied low-risk patients (pts) with differentiated thyroid cancer (DTC) less than 1 cm recruited for radioiodine therapy (RAI). Methods: 91 pts (79 women, age 48.4 ± 12 yrs) with DTC were enrolled for RAI. Patients underwent pre-therapy ultrasonography (US), those with suspected/ambiguous lymph-nodes were excluded and proposed for cytology. Treated pts underwent post-therapeutic whole body scan (WBSt) completed by neck/chest SPECT/CT, when necessary (e.g. evidence of uptake outside of thyroid bed). A target lesion on SPECT/CT was defined as an identifiable lymph-nodal site presenting a matched significant iodine uptake. The patients were followed up for 14 ± 2 months thereafter. Results: All pts/cancers were pT1. The mean histological diameter was 0.68 ± 0.23 cm. Six patients were excluded because of suspected nodal involvement at US. Thirty (35 %) out of 85 pts had suspicious WBSt as per lymph-nodal involvement which was confirmed at the subsequent SPECT/CT acquisition in most part of pts (26/30; 86 %). Overall detected target lesions was 34, and nine (26 %) had interim positive fine needle cytology. Conclusions: a significant part of low risk DTC patients, for whom RAI is not recommended, presents an incidental suspicion of lymph-nodal involvement at WBSt confirmed by subsequent SPECT/CT. Such setting would have not been treated by I-131. © 2013 Springer Science+Business Media New York.
Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer <1 cm, in the absence of other higher risk features. We retrospectively studied low-risk patients (pts) with differentiated thyroid cancer (DTC) less than 1 cm recruited for radioiodine therapy (RAI). Methods: 91 pts (79 women, age 48.4 ± 12 yrs) with DTC were enrolled for RAI. Patients underwent pre-therapy ultrasonography (US), those with suspected/ambiguous lymph-nodes were excluded and proposed for cytology. Treated pts underwent post-therapeutic whole body scan (WBSt) completed by neck/chest SPECT/CT, when necessary (e.g. evidence of uptake outside of thyroid bed). A target lesion on SPECT/CT was defined as an identifiable lymph-nodal site presenting a matched significant iodine uptake. The patients were followed up for 14 ± 2 months thereafter. Results: All pts/cancers were pT1. The mean histological diameter was 0.68 ± 0.23 cm. Six patients were excluded because of suspected nodal involvement at US. Thirty (35 %) out of 85 pts had suspicious WBSt as per lymph-nodal involvement which was confirmed at the subsequent SPECT/CT acquisition in most part of pts (26/30; 86 %). Overall detected target lesions was 34, and nine (26 %) had interim positive fine needle cytology. Conclusions: a significant part of low risk DTC patients, for whom RAI is not recommended, presents an incidental suspicion of lymph-nodal involvement at WBSt confirmed by subsequent SPECT/CT. Such setting would have not been treated by I-131. © 2013 Springer Science+Business Media New York.
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
No results. |
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
Other filter: ([btitle,keywords] "Differentiated Thyro ...
Russo M, Malandrino P, Moleti M, Vermiglio F, D'Angelo A, La Rosa G, Sapuppo G, Calaciura F, Regalbuto C, Belfiore A, Vigneri R, Pellegriti G
* Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors (288 views)
Pediatr Blood Cancer (ISSN: 1545-5009linking), 2018 Sep; 65(9): e27226-e27226.
Impact Factor: 2.513
View Export to BibTeX Export to EndNote
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
* Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience (407 views)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Impact Factor: 3.179
View Export to BibTeX Export to EndNote
Salvatore B, Klain M, Nicolai E, D'Amico D, De Matteis G, Raddi M, Fonti R, Pellegrino T, Storto G, Cuocolo A, Pace L
* Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy (394 views) (PDF 148 views)
Medicine (ISSN: 0025-7974), 2017 Oct; 96(42): e8344-e8344.
Impact Factor: 2.028
View Export to BibTeX Export to EndNote
Marotta V, Di Somma C, Rubino M, Sciammarella C, Modica R, Camera L, Del Prete M, Marciello F, Ramundo V, Circelli L, Buonomano P, Colao A, Faggiano A
* Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib (324 views)
Endocrine (ISSN: 1355-008x), 2015 Aug; 49(3): 854-858.
Impact Factor: 3.279
View Export to BibTeX Export to EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (406 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
View Export to BibTeX Export to EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (264 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
View Export to BibTeX Export to EndNote
D'Antuono F, Gallicchio R, Venetucci A, Nardelli A, Giacomobono S, Pellegrino T, Tempone A, Di Leo A, Gattozzi D, Storto G
* Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation? (253 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (456 views)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
View Export to BibTeX Export to EndNote
Barbato F, Capacchione D, Nappi A, Telesca D, Tempone A, Casolino E, Nardelli A, Castaldi E, Ortosecco G, Storto G
* Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131? (253 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (354 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (367 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Storto G, Liuzzi R, Klain M, Albanese C, Salvatore B, Pellegrino T, Cella L, Soricelli A, Pace L, Salvatore M
* Prognostic indicators in patients with differentiated thyroid cancer receiving repeated I-131 therapies (335 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (396 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (319 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
Impact Factor: 3.883
View Export to BibTeX Export to EndNote
Klain M, Pellegrino T, Storto G, Biondi B, Sansone V, Pagano L, Nicolai E, Della Morte A, D'Amico D, Soricelli A, Lombardi G, Pace L, Salvatore M
* Postsurgical follow up of differentiated thyroid cancer using rhTSH (265 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
View Export to BibTeX Export to EndNote
Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G, Salvatore M, Fenzi G, Lombardi G, Fazio S
* Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer (388 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2003 Jan; 88(1): 211-214.
Impact Factor: 5.873
View Export to BibTeX Export to EndNote
* Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors (288 views)
Pediatr Blood Cancer (ISSN: 1545-5009linking), 2018 Sep; 65(9): e27226-e27226.
Impact Factor: 2.513
View Export to BibTeX Export to EndNote
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
* Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience (407 views)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Impact Factor: 3.179
View Export to BibTeX Export to EndNote
Salvatore B, Klain M, Nicolai E, D'Amico D, De Matteis G, Raddi M, Fonti R, Pellegrino T, Storto G, Cuocolo A, Pace L
* Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy (394 views) (PDF 148 views)
Medicine (ISSN: 0025-7974), 2017 Oct; 96(42): e8344-e8344.
Impact Factor: 2.028
View Export to BibTeX Export to EndNote
Marotta V, Di Somma C, Rubino M, Sciammarella C, Modica R, Camera L, Del Prete M, Marciello F, Ramundo V, Circelli L, Buonomano P, Colao A, Faggiano A
* Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib (324 views)
Endocrine (ISSN: 1355-008x), 2015 Aug; 49(3): 854-858.
Impact Factor: 3.279
View Export to BibTeX Export to EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (406 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
View Export to BibTeX Export to EndNote
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
* Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (264 views)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
Impact Factor: 4.278
View Export to BibTeX Export to EndNote
D'Antuono F, Gallicchio R, Venetucci A, Nardelli A, Giacomobono S, Pellegrino T, Tempone A, Di Leo A, Gattozzi D, Storto G
* Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation? (253 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
View Export to BibTeX Export to EndNote
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (456 views)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
View Export to BibTeX Export to EndNote
Barbato F, Capacchione D, Nappi A, Telesca D, Tempone A, Casolino E, Nardelli A, Castaldi E, Ortosecco G, Storto G
* Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131? (253 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
View Export to BibTeX Export to EndNote
Pace L, Nicolai E, Klain M, Salvatore M
* Diagnostic value of FDG PET/CT imaging (354 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (367 views)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
Impact Factor: 1.724
View Export to BibTeX Export to EndNote
Storto G, Liuzzi R, Klain M, Albanese C, Salvatore B, Pellegrino T, Cella L, Soricelli A, Pace L, Salvatore M
* Prognostic indicators in patients with differentiated thyroid cancer receiving repeated I-131 therapies (335 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (396 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
Impact Factor: 4.041
View Export to BibTeX Export to EndNote
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (319 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
Impact Factor: 3.883
View Export to BibTeX Export to EndNote
Klain M, Pellegrino T, Storto G, Biondi B, Sansone V, Pagano L, Nicolai E, Della Morte A, D'Amico D, Soricelli A, Lombardi G, Pace L, Salvatore M
* Postsurgical follow up of differentiated thyroid cancer using rhTSH (265 views)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
View Export to BibTeX Export to EndNote
Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G, Salvatore M, Fenzi G, Lombardi G, Fazio S
* Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer (388 views)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2003 Jan; 88(1): 211-214.
Impact Factor: 5.873
View Export to BibTeX Export to EndNote
16 Records (12 excluding Abstracts).
Total impact factor: 58.382 (40.153 excluding Abstracts).
Total 5 year impact factor: 51.662 (32.813 excluding Abstracts).
Total impact factor: 58.382 (40.153 excluding Abstracts).
Total 5 year impact factor: 51.662 (32.813 excluding Abstracts).
430 views. Last view on Sunday 05 March 2023, 6:20:27
ibb.cnr.it
